Stay informed with news and resources on Zika, including signs and symptoms, prevention strategies and more.
Stay informed with news and resources on pertussis (whooping cough), including signs and symptoms, prevention strategies and more.
Burnout rate improving among physicians, though rates remain high since 2011. Learn more.
AMA welcomes effort to address decades of falling payment while detailing how proposed Medicaid changes will lead to coverage interruptions.
From billing to workflow, a series of courses gives medical students practical insight into the business operations that help a modern practice thrive.
Residency programs need to teach the ethical standards that come with clinical trials. An AMA education module aids that teaching process.
Latest NRMP survey shows how program directors are really using signals sent by residency applicants. Learn how to build a smart signaling strategy.
Not sure how UWorld QBanks can help you in your studies? The AMA offers some frequently asked questions and answers to give you more insight.
From intern to senior resident, every step in GME brings new challenges. These tips can help you meet them like a seasoned professional.
Proposed legislation, backed by the AMA, offers interest-free student-loan deferment during residency, aiming to reduce debt and increase career flexibility.
Collaborating and networking to advocate for patients and the medical profession.
AMA Advocacy Insights webinar series examines key advocacy issues from the federal and state levels impacting patients and physicians.
This two-day boot camp, Sept. 17-18, 2025, will equip attendees with the time-saving tools and strategies to reform their organizations and enhance professional satisfaction.
ChangeMedEd® is a national conference that brings together leaders and innovators to accelerate change in medical education across the continuum. Learn more.
Download and review the PDF list of pending reports from the Board and the councils, and submit comments and feedback.
Find out about the election bylaws and policies for being elected to the AMA House of Delegates.
Apply for a leadership position by submitting the required documentation by the deadline.
See how CSAPH works to represent the AMA’s core belief that scientific evidence is the basis for improving the quality of patient care.
Explore the guidelines for establishing an observership program for international medical graduates (IMGs).
Read current and previous issues of YPS Members & News Highlights to find out how young physicians advocate for patients and the various issues impacting health care.
Watch the video of a fireside chat with AMA leadership answering questions from members about what AMA is doing to address changes under the new administration.
Dr. Whyte brings digital savvy, health policy expertise and clinical experience to shape a new era in medicine.
AMA Task Force to Reduce Opioid Abuse is now a part of the larger AMA Substance Use and Pain Care Task Force. Please visit the AMA Substance Use and Pain Care Task Force to learn more.
The pandemic is exacerbating the ongoing opioid epidemic. The AMA is calling on states to take specific steps to save lives, reduce harm and get patients treatment they need.
Updated state-based COVID-19 resources and more in the latest State Advocacy Update.
New AMA web page to help states respond to COVID-19 and more in the latest State Adovcacy Update.
In the latest Advoaccy Update, the AMA called on governors to adopt civil immunity for physicians providing COVID-19-related care.
Advocacy spotlights new cyber treats during COVID-19 and physician protections as well as new policies for opioid treatment programs.
The blanket exception will allow patients to obtain up to 28 days of take-home medication if they are stable and up to 14 days for patients who are less stable.
Medications for addiction treatment (MAT) are underused, with racial, geographic and economic barriers. Learn about a Big Apple initiative that’s making big changes.
James Baker, MD, whose son died of an overdose at 23, provides phone support to primary care doctors treating patients with substance-use disorders.
Warning on naloxone in CO, prior authorization in ME and more in AMA's latest state advocacy efforts.
